Published in Neurology on November 12, 2002
Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity. Neurology (2013) 1.82
Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia (2007) 1.81
HIV-associated neurocognitive disorder. Lancet Infect Dis (2013) 1.60
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57
Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2004) 1.56
Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health (2004) 1.54
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev (2008) 1.52
Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve. Brain (2009) 1.45
The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One (2012) 1.27
Declined neural efficiency in cognitively stable human immunodeficiency virus patients. Ann Neurol (2009) 1.26
Different activation patterns for working memory load and visual attention load. Brain Res (2006) 1.25
Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol (2012) 1.23
Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS Behav (2012) 1.19
Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res (2011) 1.13
Lower cognitive reserve in the aging human immunodeficiency virus-infected brain. Neurobiol Aging (2012) 1.11
Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacol (2012) 1.08
fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence. Psychiatry Res (2011) 1.07
Regional cortical thinning associated with detectable levels of HIV DNA. Cereb Cortex (2011) 1.02
Compensatory cortical activation during performance of an attention task by patients with diffuse axonal injury: a functional magnetic resonance imaging study. J Neurol Neurosurg Psychiatry (2006) 1.02
Antiretroviral treatment is associated with increased attentional load-dependent brain activation in HIV patients. J Neuroimmune Pharmacol (2007) 0.98
Neuroimaging research in human MDMA users: a review. Psychopharmacology (Berl) (2006) 0.97
Functional connectivity measured with magnetoencephalography identifies persons with HIV disease. Brain Imaging Behav (2012) 0.96
Cognitive impairment in patients with AIDS - prevalence and severity. HIV AIDS (Auckl) (2015) 0.96
The human immunodeficiency virus reduces network capacity: acoustic noise effect. Ann Neurol (2006) 0.96
Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease. Neurobiol Dis (2010) 0.94
Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study. Neuropsychologia (2009) 0.94
Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease. J Neurosci Methods (2012) 0.92
Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol (2013) 0.92
Functional brain abnormalities during finger-tapping in HIV-infected older adults: a magnetoencephalography study. J Neuroimmune Pharmacol (2013) 0.91
Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered. Curr HIV/AIDS Rep (2015) 0.90
Functional MRI study of working memory in MDMA users. Psychopharmacology (Berl) (2004) 0.90
Altered prefronto-striato-parietal network response to mental rotation in HIV. J Neurovirol (2012) 0.88
Role of neuroimaging in HIV-associated neurocognitive disorders. Semin Neurol (2014) 0.88
Neuroimaging of HIV-associated neurocognitive disorders (HAND). Curr Opin HIV AIDS (2014) 0.88
Disruption of emotion and conflict processing in HIV infection with and without alcoholism comorbidity. J Int Neuropsychol Soc (2011) 0.88
Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase. Neurotherapeutics (2010) 0.84
Cognitive reserve protects against apathy in individuals with human immunodeficiency virus. Arch Clin Neuropsychol (2013) 0.84
Mapping mental number line in physical space: vertical and horizontal visual number line orientation in asymptomatic individuals with HIV. Neuropsychologia (2008) 0.84
Decreased MEG beta oscillations in HIV-infected older adults during the resting state. J Neurovirol (2013) 0.83
Multimodal neuroimaging evidence of alterations in cortical structure and function in HIV-infected older adults. Hum Brain Mapp (2014) 0.82
Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline. J Cereb Blood Flow Metab (2015) 0.82
Abnormal MEG oscillatory activity during visual processing in the prefrontal cortices and frontal eye-fields of the aging HIV brain. PLoS One (2013) 0.82
Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. J Neurovirol (2014) 0.82
Disruption of neuronal CXCR4 function by opioids: preliminary evidence of ferritin heavy chain as a potential etiological agent in neuroAIDS. J Neuroimmunol (2010) 0.81
Neurocognitive correlates of alexithymia in asymptomatic individuals with HIV. Neuropsychologia (2009) 0.81
Genetic predictor of working memory and prefrontal function in women with HIV. J Neurovirol (2014) 0.81
Altered functional response to risky choice in HIV infection. PLoS One (2014) 0.81
White matter fiber compromise contributes differentially to attention and emotion processing impairment in alcoholism, HIV-infection, and their comorbidity. Neuropsychologia (2012) 0.81
Neural dysregulation during a working memory task in human immunodeficiency virus-seropositive and hepatitis C coinfected individuals. J Neurovirol (2014) 0.81
Modeling deficits in attention, inhibition, and flexibility in HAND. J Neuroimmune Pharmacol (2014) 0.81
HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study. J Int Neuropsychol Soc (2015) 0.80
The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review. CNS Drugs (2016) 0.80
An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research. Curr Drug Abuse Rev (2015) 0.79
Prefrontal cortical thinning in HIV infection is associated with impaired striatal functioning. J Neural Transm (Vienna) (2016) 0.78
Visualization and quantification of simian immunodeficiency virus-infected cells using non-invasive molecular imaging. J Gen Virol (2015) 0.78
Review of functional MRI in HIV: effects of aging and medication. J Neurovirol (2016) 0.78
Neurobehavioral assessment in forensic practice. Int J Law Psychiatry (2012) 0.76
Neural correlates of working memory training in HIV patients: study protocol for a randomized controlled trial. Trials (2016) 0.76
Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task. Neurobiol Dis (2015) 0.75
The impact of marijuana use on memory in HIV-infected patients: a comprehensive review of the HIV and marijuana literatures. Curr Drug Abuse Rev (2016) 0.75
The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections. Neurotherapeutics (2011) 0.75
Aberrant Neuronal Dynamics during Working Memory Operations in the Aging HIV-Infected Brain. Sci Rep (2017) 0.75
Motor-related brain abnormalities in HIV-infected patients: a multimodal MRI study. Neuroradiology (2017) 0.75
Mechanisms of Cognitive Aging in the HIV-Positive Adult. Curr Behav Neurosci Rep (2017) 0.75
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev (1998) 6.74
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Sexual health education interventions for young people: a methodological review. BMJ (1995) 4.18
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet (2007) 4.13
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 4.06
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci (1999) 3.55
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol (1998) 2.77
JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther (2005) 2.71
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (1995) 2.62
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev (1999) 2.56
Isolation and characterization of new fission yeast cytokinesis mutants. Genetics (1998) 2.51
Single virus detection from the reactive shift of a whispering-gallery mode. Proc Natl Acad Sci U S A (2008) 2.49
Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology (2000) 2.26
V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2001) 2.19
Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2014) 2.17
Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem (2001) 2.14
Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst (2001) 2.12
Prospective comparison treatment of 595-nm pulsed-dye lasers for virgin port-wine stain. Br J Dermatol (2015) 1.96
Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology (1997) 1.94
Childhood lead exposure in Trail revisited. Can J Public Health (1992) 1.89
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology (1997) 1.78
Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology (2009) 1.76
The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther (2004) 1.76
Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. Free Radic Biol Med (2000) 1.71
Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer (2004) 1.66
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med (2001) 1.64
Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol (2001) 1.63
Review article: the treatment of functional abdominal bloating and distension. Aliment Pharmacol Ther (2011) 1.63
The role of the sid1p kinase and cdc14p in regulating the onset of cytokinesis in fission yeast. EMBO J (2000) 1.62
fMRI-acoustic noise alters brain activation during working memory tasks. Neuroimage (2005) 1.60
Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice. Can Fam Physician (1998) 1.59
Functional GI disorders: from animal models to drug development. Gut (2007) 1.55
Neural correlates of attention and working memory deficits in HIV patients. Neurology (2001) 1.55
Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol Motil (2013) 1.55
Bose-Einstein condensation in microgravity. Science (2010) 1.54
Unsuspected atypical hemispheric dominance for language as determined by fMRI. Epilepsia (2001) 1.52
Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry (2001) 1.52
Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome. J Pediatr (2000) 1.52
Cytochrome C oxidase and the regulation of oxidative phosphorylation. Chembiochem (2001) 1.52
Mapping quantitative trait loci controlling agronomic traits in the spring wheat cross RL4452x'AC Domain'. Genome (2005) 1.51
Sebaceous adenitis in the Akita: clinical observations, histopathology and heredity. Vet Dermatol (2001) 1.49
Identification of conserved, RpoS-dependent stationary-phase genes of Escherichia coli. J Bacteriol (1998) 1.49
Brain areas specific for attentional load in a motion-tracking task. J Cogn Neurosci (2001) 1.48
Gender-related differences in IBS symptoms. Am J Gastroenterol (2001) 1.47
In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci (1996) 1.46
Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol (2011) 1.46
Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest (1982) 1.46
Homozygosity for DNASE2 single nucleotide polymorphisms in the 5'-regulatory region is associated with rheumatoid arthritis. Ann Rheum Dis (2008) 1.45
Autoantibodies in systemic vasculitis. Aust N Z J Med (1991) 1.44
A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J Biol Chem (1999) 1.43
Practice-induced changes of brain function during visual attention: a parametric fMRI study at 4 Tesla. Neuroimage (2004) 1.42
Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol (2000) 1.38
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol (1992) 1.37
Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut (2005) 1.37
Fragmented condensate ground state of trapped weakly interacting bosons in two dimensions. Phys Rev Lett (2001) 1.36
Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics. Dementia (1993) 1.35
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology (2001) 1.35
Thalamic metbolism and corticospinal tract integrity determine motor recovery in stroke. Ann Neurol (1996) 1.34
Gender differences in the functional organization of the brain for working memory. Neuroreport (2000) 1.33
Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy. AJNR Am J Neuroradiol (2001) 1.32
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes. J Med Chem (1998) 1.31
Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology (2001) 1.30
Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology (1997) 1.30
Kinetic analyses of stability of simple and complex retroviral vectors. Virology (2001) 1.28
Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors. Am J Physiol (1998) 1.28
Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology (1995) 1.27
A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res (1997) 1.27
Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology (1993) 1.25
Different activation patterns for working memory load and visual attention load. Brain Res (2006) 1.25
Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr Diabetes (2011) 1.23
Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain (2000) 1.23
AP-1--glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol (2001) 1.22
NIOSH life table program for personal computers. Am J Ind Med (1998) 1.20
Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol (1999) 1.19
Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax (2006) 1.18
Aggressive confusional state as a clinical manifestation of status epilepticus in MELAS. Neurology (2003) 1.18
Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage (2003) 1.18
Pyrroles and other heterocycles as inhibitors of p38 kinase. Bioorg Med Chem Lett (1998) 1.18
Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev (1997) 1.18
Interferometry with Bose-Einstein condensates in microgravity. Phys Rev Lett (2013) 1.17
A multicenter investigation with D-FISH BCR/ABL1 probes. Cancer Genet Cytogenet (2000) 1.16
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale. Aliment Pharmacol Ther (2009) 1.16
Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol (2001) 1.15
Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J (1993) 1.14
Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J Biol Chem (1995) 1.14
Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther (2010) 1.14
Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil (2012) 1.14